Warning Letter Roundup: Five Firms Draw Letters for Faulty Procedures By Sam | April 10, 2018 The FDA issued warnings to three overseas and two U.S. facilities for a variety of nonconformances including inadequate testing. Source: Drug GMP Report Posted in Drug GMP Report